Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fukazawa

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
The Journal of Pharmacy and Pharmacology|July 1, 1994
The disposition of the tolcapone 3-O-methylated metabolite is affected by the route of administration in ratsT Funaki, H Onodera, N Ushiyama, et al.
Mutation Research|October 12, 2000
Chlorination of harman and norharman with sodium hypochlorite and co-mutagenicity of the chlorinated productsK Nakano, K Suyama, H Fukazawa, et al.
Clinical Cardiology|March 9, 1999
Myotonic dystrophy associated with QT prolongation and torsade de pointesY Umeda, U Ikeda, J Yamamoto, et al.
Thyroid : Official Journal of the American Thyroid Association|May 13, 1999
Increased serum soluble Fas in patients with Graves' diseaseY Hiromatsu, T Bednarczuk, E Soyejima, et al.
Head & Neck|January 1, 1994
Multidisciplinary treatment of head and neck cancer using BCG, OK-432, and GE-132 as biologic response modifiersH Fukazawa, Y Ohashi, S Sekiyama, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1984
Metabolism of tenoxicam in ratsS Ichihara, Y Tsuyuki, H Tomisawa, et al.
The Review of Scientific Instruments|May 17, 2007
Manometer extension for high pressure measurement: nuclear quadrupole resonance study of Cu2O with a modified Bridgman anvil cell up to 10 GPaH Fukazawa, N Yamatoji, Y Kohori, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Effects of thyroid hormone on carbonic anhydrase I levels in human erythroid (YN-1) cellsK Kikuchi, K Yoshida, K Endo, et al.
Biochemical Pharmacology|October 23, 1997
Interaction of the DNA topoisomerase II catalytic inhibitor meso-2,3-bis(3,5-dioxopiperazine-1-yl)butane (ICRF-193), a bisdioxopiperazine derivative, with the conserved region(s) of eukaryotic but not prokaryotic enzymeM Sato, R Ishida, T Narita, et al.
Oncogene|April 4, 2006
Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activationA Masumi, H Fukazawa, T Shimazu, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Pharmacy and Pharmacology|July 1, 1994
The disposition of the tolcapone 3-O-methylated metabolite is affected by the route of administration in ratsT Funaki, H Onodera, N Ushiyama, et al.
Mutation Research|October 12, 2000
Chlorination of harman and norharman with sodium hypochlorite and co-mutagenicity of the chlorinated productsK Nakano, K Suyama, H Fukazawa, et al.
Clinical Cardiology|March 9, 1999
Myotonic dystrophy associated with QT prolongation and torsade de pointesY Umeda, U Ikeda, J Yamamoto, et al.
Thyroid : Official Journal of the American Thyroid Association|May 13, 1999
Increased serum soluble Fas in patients with Graves' diseaseY Hiromatsu, T Bednarczuk, E Soyejima, et al.
Head & Neck|January 1, 1994
Multidisciplinary treatment of head and neck cancer using BCG, OK-432, and GE-132 as biologic response modifiersH Fukazawa, Y Ohashi, S Sekiyama, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1984
Metabolism of tenoxicam in ratsS Ichihara, Y Tsuyuki, H Tomisawa, et al.
The Review of Scientific Instruments|May 17, 2007
Manometer extension for high pressure measurement: nuclear quadrupole resonance study of Cu2O with a modified Bridgman anvil cell up to 10 GPaH Fukazawa, N Yamatoji, Y Kohori, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Effects of thyroid hormone on carbonic anhydrase I levels in human erythroid (YN-1) cellsK Kikuchi, K Yoshida, K Endo, et al.
Biochemical Pharmacology|October 23, 1997
Interaction of the DNA topoisomerase II catalytic inhibitor meso-2,3-bis(3,5-dioxopiperazine-1-yl)butane (ICRF-193), a bisdioxopiperazine derivative, with the conserved region(s) of eukaryotic but not prokaryotic enzymeM Sato, R Ishida, T Narita, et al.
Oncogene|April 4, 2006
Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activationA Masumi, H Fukazawa, T Shimazu, et al.
Pageof 15